secwatch.observer — SEC 8-K summary
======================================

Issuer:     Neurogene Inc. (NGNE)
CIK:        0001404644
Form:       8-K
Filed at:   2022-11-30T23:59:59+00:00
Accession:  0001628280-22-031095
Event type: other
Sentiment:  neutral
Materiality: 0.15
Item codes: 5.03, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Neoleukin adopts amended bylaws updating DGCL, universal proxy, advance notice, exclusive forum
--------------------------------------------------------------------------------

- Advance notice period changed to 75-105 days before meeting anniversary (was 90-120).
- Universal proxy (Rule 14a-19) compliance: shareholder must certify, provide reasonable evidence 5 business days before meeting.
- Exclusive forum for derivative, fiduciary duty, DGCL, and internal affairs claims remains Delaware Court of Chancery or federal district court.
- Indemnification now requires good faith or no reasonable cause to believe conduct unlawful; emergency bylaw added.
- Electronic transmission of notices permitted; meeting conduct clarified for presiding officer and Rule 14a-8 proponents.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1404644/000162828022031095/0001628280-22-031095-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1404644/000162828022031095/nltx-20221130.htm
  HTML page:      https://secwatch.observer/filing/0001628280-22-031095

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer